Congenital hypothyroidism: etiology and growth-development outcome

Setila Dalili1, Seyed Mahmood Rezvani2, Hossein Dalili3

  • 1Pediatrics Growth Disorders Research Center, 17 Shahrivar Hospital, Faculty of Medicine, Guilan University of Medical Sciences, Guilan, Iran. setiladalili1346@yahoo.com.

Acta Medica Iranica
|November 5, 2014
PubMed

Insights

Neonatal screening and early treatment of congenital hypothyroidism (CH) lead to normal growth and development in children. This study in Iran found CH incidence at 1:781, with most cases being transient and effectively managed.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Congenital hypothyroidism (CH) is a leading preventable cause of intellectual and growth deficits.
  • Early detection and management are crucial for optimal outcomes in affected neonates.

Purpose of the Study:

  • To investigate the growth and mental outcomes of children diagnosed with congenital hypothyroidism.
  • To determine the incidence and etiological factors of CH in Guilan province, Iran.

Main Methods:

  • Screening of 28,904 neonates for CH between November 2006 and November 2007.
  • Etiological evaluation using laboratory tests, thyroid sonography, or scan.
  • Comparison of growth and developmental parameters (height, weight, head circumference, IQ) at four years of age with a control group.

Main Results:

  • CH incidence was 1:781 live births, with 54% female and 46% male cases.
  • Transient hypothyroidism (56.8%) was more common than permanent CH (43.2%).
  • Permanent CH cases were primarily due to dyshormonogenesis (68.2%) or thyroid dysgenesis (31.2%).
  • A positive family history of thyroid disease was significantly higher in CH patients (34.3%) versus controls (13.2%, P=0.03).
  • No significant differences in demographic characteristics or IQ were observed between CH patients and controls.
  • Treated CH patients demonstrated normal growth, indicating effective screening and treatment protocols.

Conclusions:

  • Neonatal screening and timely treatment of congenital hypothyroidism result in normal growth and development.
  • The screening program in Guilan province is effective in identifying and managing CH.
  • Family history is a significant risk factor for congenital hypothyroidism.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
11
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
5.6K
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
7
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
3
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
8
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
8